Common genetic variation in DDAH2 is associated with intracerebral haemorrhage in a Chinese population: A multi-centre case-control study in China

Clinical Science

Volumn 117, Issue 7, 2009, Pages 273-279

  Bai, Yongyi ^a,b   Chen, Jingzhou ^a   Sun, Kai ^a   Xin, Ying ^a   Liu, Junhao ^a   Hui, Rutai ^a,b  

^a Sino German Laboratory for Molecular Medicine   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Asymmetric NG,NG dimethylarginine (ADMA); Dimethylarginine dimethylaminohydrolase 2 (DDAH2); Intracerebral haemorrhage; Nitric oxide synthase (NOS); Risk factor; Stroke

Indexed keywords

DIMETHYLARGININASE; DIMETHYLARGININASE 2; UNCLASSIFIED DRUG; AMIDASE;

ADULT; ARTICLE; BRAIN HEMORRHAGE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; FEMALE; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION GENETICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN; CLINICAL TRIAL; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MULTICENTER STUDY; RISK FACTOR; STROKE;

AMIDOHYDROLASES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CEREBRAL HEMORRHAGE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; STROKE;

EID: 70249134070     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20090005     Document Type: Article

References (29)

1. World Health Organization (1994) World Health Statistics Annual, 1993, World Health Organization, Geneva, Switzerland
2. Tunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A. M. and Pajak, A. (1994) Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90, 583-612
3. Reed, D. M. (1990) The paradox of high risk of stroke in populations with low risk of coronary heart disease. Am. J. Epidemiol. 131, 579-588
4. National 8.5 CVD collaborative Group (1998) Community comprehensive preventive study on cardial and cerebral vascular diseases. Chin. J. Prevent. Med. 32, 3-4
5. Shi, F. L., Hart, R. G., Sherman, D. G. and Tegeler, C. H. (1989) Stroke in the People's Republic of China. Stroke 20, 1581-1585
6. He, J., Klag, M. J., Wu, Z. and Whelton, P. K. (1995) Stroke in the People's Republic of China. I. Geographic variations in incidence and risk factors. Stroke 26, 2222-2227
7. Yang, Q. D., Niu, Q., Zhou, Y. H., Liu, Y. H., Xu, H. W., Gu, W. P., Tian, F. F., Xie, Y. Q., Zhang, L. and Xia, J. (2004) Incidence of cerebral hemorrhage in the Changsha community. A prospective study from 1986 to 2000. Cerebrovasc. Dis. 17, 303-313
8. Abbott, R. D., Curb, J. D., Rodriguez, B. L., Masaki, K. H., Popper, J. S., Ross, G. W. and Petrovitch, H. (2003) Age-related changes in risk factor effects on the incidence of thromboembolic and hemorrhagic stroke. J. Clin. Epidemiol. 56, 479-486
9. Rost, N. S., Greenberg, S. M. and Rosand, J. (2008) The genetic architecture of intracerebral hemorrhage. Stroke 39, 2166-2173
10. Kawashima, S., Yamashita, T., Ozaki, M., Ohashi, Y., Azumi, H., Inoue, N., Hirata, K., Hayashi, Y., Itoh, H. and Yokoyama, M. (2001) Endothelial NO synthase overexpression inhibits lesion formation in mouse model of vascular remodeling. Arterioscler. Thromb. Vasc. Biol. 21, 201-207
11. Vallance, P. and Leiper, J. (2004) Cardiovascular biology of the asymmetric dimethylarginine: dimethylarginine dimethylaminohydrolase pathway. Arterioscler. Thromb. Vasc. Biol. 24, 1023-1030
12. McBride, A. E. and Silver, P. A. (2001) State of the arg: protein methylation at arginine comes of age. Cell 106, 5-8
13. G-dimethylarginine dimethylaminohydrolase, from rat kidney. J. Biol. Chem. 264, 10205-10209
14. G-dimethylarginine dimethylaminohydrolase in human tissues using a monoclonal antibody. J. Biochem. (Tokyo) 117, 237-238
15. The MHC Sequencing Consortium (1999) Complete sequence and gene map of a human major histocompatibility complex. Nature 401, 921-923
16. Practice Management Information Corporation (1995) International Classification of Diseases, 9th revision. In Clinical Modification, 4th edn, Practice Management Information Corporation (PMIC), Los Angeles
17. Fisher, C. M. (1982) Lacunar strokes and infarcts: a review. Neurology 32, 871-876
18. O'Donnell, C. J., Lindpaintner, K., Larson, M. G., Rao, V. S., Ordovas, J. M., Schaefer, E. J., Myers, R. H. and Levy, D. (1998) Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 97, 1766-1772
19. O'Dwyer, M. J., Dempsey, F., Crowley, V., Kelleher, D. P., McManus, R. and Ryan, T. (2006) Septic shock is correlated with asymmetrical dimethyl arginine levels, which may be influenced by a polymorphism in the dimethylarginine dimethylaminohydrolase II gene: a prospective observational study. Crit. Care 10, R139
20. Wang, Y., Zhang, W., Zhang, Y., Yang, Y., Sun, L., Hu, S., Chen, J., Zhang, C., Zheng, Y., Zhen, Y. et al. (2006) VKORC1 haplotypes are associated with arterial vascular diseases (stroke, coronary heart disease, and aortic dissection). Circulation 113, 1615-1623
21. Pritchard, J. K. and Rosenberg, N. A. (1999) Use of unlinked genetic markers to detect population stratification in association studies. Am. J. Hum. Genet. 65, 220-228
22. Greenberg, S. M. (2006) Small vessels, big problems. N. Engl. J. Med. 354, 1451-1453
23. Dufouil, C., Chalmers, J., Coskun, O., Besançon, V., Bousser, M. G., Guillon, P., MacMahon, S., Mazoyer, B., Neal, B., Woodward, M. et al. (2005) Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation 112, 1644-1650
24. Wojciak-Stothard, B., Torondel, B., Tsang, L. Y., Fleming, I., Fisslthaler, B., Leiper, J. M. and Vallance, P. (2007) The ADMA/DDAH pathway is a critical regulator of endothelial cell motility. J. Cell Sci. 120, 929-942
25. Dayoub, H., Rodionov, R. N., Lynch, C., Cooke, J. P., Arning, E., Bottiglieri, T., Lentz, S. R. and Faraci, F. M. (2008) Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation. Stroke 39, 180-184
26. Toth, J., Racz, A., Kaminski, P. M., Wolin, M. S., Bagi, Z. and Koller, A. (2007) Asymmetrical dimethylarginine inhibits shear stress-induced nitric oxide release and dilation and elicits superoxide-mediated increase in arteriolar tone. Hypertension 49, 563-568
27. Kielstein, J. T., Donnerstag, F., Gasper, S., Menne, J., Kielstein, A., Martens-Lobenhoffer, J., Scalera, F., Cooke, J. P., Fliser, D. and Bode-Böger, S. M. (2006) ADMA increases arterial stiffness and decreases cerebral blood flow in humans. Stroke 37, 2024-2029
28. Scalera, F., Borlak, J., Beckmann, B., Martens-Lobenhoffer, J., Thum, T., Täger, M. and Bode-Böger, S. M. (2004) Endogenous nitric oxide synthesis inhibitor asymmetric dimethyl L-arginine accelerates endothelial cell senescence. Arterioscler. Thromb. Vasc. Biol. 24, 1816-1822
29. Augustyniak, R. A., Victor, R. G., Morgan, D. A. and Zhang, W. (2006) L-NAME- and ADMA-induced sympathetic neural activation in conscious rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290, R726-R732